STIZON
Desconocido
EMIF: European Medical Information Framework
Stichting Informatievoorziening voor Zorg en Onderzoek
participó en un
FP7:
In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected,...
Financiado
Financiado
EU-ADR: Exploring and understanding adverse drug reactions by integrative mining of clinical records and bio...
Stichting Informatievoorziening voor Zorg en Onderzoek
participó en un
FP7:
Serious adverse effects resulting from the treatment with thalidomide prompted modern drug legislation more than 40 years ago. Post-marketin...
Financiado
Financiado
SAFEGUARD: Safety Evaluation of Adverse Reactions in Diabetes
Stichting Informatievoorziening voor Zorg en Onderzoek
participó en un
FP7:
"In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated w...
Financiado
Financiado
SOS: Safety Of non Steroidal anti inflammatory drugs
Stichting Informatievoorziening voor Zorg en Onderzoek
participó en un
FP7:
The Safety Of non-Steroidal anti-inflammatory drugs (SOS) proposal aims to assess the relative cardiovascular (CVD) and gastrointestinal (GI...
Financiado
Financiado
ARITMO: Arrhythmogenic potential of drugs
Stichting Informatievoorziening voor Zorg en Onderzoek
participó en un
FP7:
The ability of some compounds to prolong the QT interval of the electrocardiogram and to precipitate Torsade de Pointes (TdP, a potentially...
Financiado
Financiado
* No se disponen de datos de la empresa actual.